Patrizio Giacomini Selected Research

Patrizio Giacomini Research Topics

Disease

27	Neoplasms (Cancer) 04/2021 - 07/2003
8	Melanoma (Melanoma, Malignant) 04/2021 - 04/2006
6	Breast Neoplasms (Breast Cancer) 11/2021 - 09/2006
5	Carcinoma (Carcinomatosis) 10/2015 - 04/2006
4	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 06/2018
3	Neuroblastoma 01/2012 - 05/2008
2	Lymphoma (Lymphomas) 03/2011 - 04/2006
1	Circulating Neoplastic Cells 08/2020
1	Sarcoma (Soft Tissue Sarcoma) 08/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2011
1	Carcinogenesis 05/2008
1	Nevus (Nevi) 06/2006
1	Leukemia 04/2006

Drug/Important Bio-Agent (IBA)

5	LigandsIBA 10/2015 - 09/2011
4	Ferritins (Ferritin)IBA 02/2021 - 12/2013
4	MicroRNAs (MicroRNA)IBA 08/2020 - 05/2008
4	Peptides (Polypeptides)IBA 10/2016 - 04/2006
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 07/2003
4	AminopeptidasesIBA 01/2012 - 04/2006
3	Cell-Free Nucleic AcidsIBA 01/2021 - 10/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 06/2017
3	Proteins (Proteins, Gene)FDA Link 08/2017 - 12/2013
3	HLA-A Antigens (HLA-A)IBA 01/2014 - 01/2007
2	Peptide Hydrolases (Proteases)FDA Link 02/2021 - 04/2006
2	Immunoglobulin FragmentsIBA 01/2021 - 11/2005
2	ErbB Receptors (EGF Receptor)IBA 12/2020 - 09/2006
2	Circulating Tumor DNAIBA 04/2020 - 06/2018
2	HLA-C Antigens (HLA-C)IBA 01/2014 - 01/2007
2	HLA-B Antigens (HLA-B)IBA 01/2014 - 01/2007
2	Monoclonal AntibodiesIBA 12/2013 - 01/2007
2	NF-kappa B (NF-kB)IBA 01/2012 - 02/2010
2	Formaldehyde (Formol)FDA Link 10/2011 - 01/2007
2	ParaffinIBA 10/2011 - 01/2007
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	Drug CarriersIBA 02/2021
1	Topoisomerase I InhibitorsIBA 02/2021
1	Genz-644282IBA 02/2021
1	ferritin receptorIBA 02/2021
1	Peptide Nucleic AcidsIBA 01/2021
1	ProdrugsIBA 01/2021
1	EWS-FLI fusion proteinIBA 01/2018
1	ApoferritinsIBA 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2016
1	Matrix Metalloproteinases (MMPs)IBA 10/2016
1	Vitamin K 3 (Menadione)FDA Link 10/2015
1	micaIBA 10/2015
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2015
1	VitaminsIBA 10/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	Succinic Acid (Succinate)IBA 10/2015
1	NK Cell Lectin-Like Receptor Subfamily KIBA 10/2015
1	HLA-G Antigens (HLA G)IBA 01/2014
1	ThymidineIBA 12/2013
1	AntigensIBA 12/2013
1	Immunoconjugates (Immunoconjugate)IBA 12/2013
1	Cisplatin (Platino)FDA LinkGeneric 12/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2013
1	Antiviral Agents (Antivirals)IBA 10/2013
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 10/2013
1	fluorexon (calcein)IBA 10/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2013
1	Antineoplastic Agents (Antineoplastics)IBA 02/2013
1	Dinoprostone (PGE2)FDA Link 02/2013
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2013
1	Biological ProductsIBA 05/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2012
1	NK Cell Lectin-Like Receptor Subfamily CIBA 10/2011
1	Histocompatibility Antigens Class IIBA 03/2011
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2009
1	EpitopesIBA 03/2009
1	AntagomirsIBA 05/2008
1	3' Untranslated Regions (3' UTR)IBA 05/2008
1	Messenger RNA (mRNA)IBA 05/2008
1	Coloring Agents (Dyes)IBA 01/2007
1	Epidermal Growth Factor (EGF)IBA 09/2006
1	AntibodiesIBA 09/2006
1	TetraspaninsIBA 06/2006
1	Collagen Type VIIBA 06/2006
1	Complementary DNA (cDNA)IBA 06/2006

Therapy/Procedure

10	Therapeutics 02/2021 - 11/2005
3	Immunotherapy 04/2021 - 03/2009
2	Precision Medicine 04/2021 - 08/2020
1	Neoadjuvant Therapy 01/2018
1	Chemoprevention 10/2015
1	Intravenous Administration 12/2013
1	Combination Drug Therapy (Combination Chemotherapy) 12/2013
1	Bioreactors (Bioreactor) 09/2006